Post-op shoe market projected to hit $1.1 billion by 2031

A new Allied Market Research report says the global post-op shoe market is on track to nearly double from 2021 levels by 2031, driven by demand for products used after foot and ankle surgery or injury. North America leads the market now, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The post-op shoe market is projected to reach $1.1 billion by 2031, up from $634.5 million in 2021. - The forecast implies steady demand for recovery footwear used after surgery and foot or ankle injuries. - Semi-rigid products are expected to remain a major growth pocket within the category.

What happened: - Allied Market Research published a new report on the global post-op shoe market. - The market is estimated to grow at a 5.1% CAGR from 2022 to 2031. - The report covers rigid sole, soft sole and semi-rigid sole products, as well as adult and children end users. - The report also segments sales through medical and pharma stores, specialty stores and online retail across North America, Europe, Asia-Pacific and LAMEA. - The report includes a sample PDF request and a purchase inquiry page.

The details: - Post-op shoes are generally used after surgery or for foot and ankle injuries. - Common product examples include adjustable Darco med post-op surg shoe, Darco slimline cast boot, EZ Walking foot and ankle support cast boot, canvas rocker bottom cast shoe and pediatric classic post-op shoe with buckle closure. - The semi-rigid segment was valued at $298.1 million in 2021 and is projected to reach $492.7 million by 2031. - Semi-rigid products are expected to grow at a 5.2% CAGR. - The adult end-user segment is also expected to grow at a 5.2% CAGR during the forecast period. - The adult segment generates the largest revenue share because of rising foot and ankle injuries among adults. - The medical and pharma store channel was valued at $266.0 million in 2021 and is expected to reach $438.1 million by 2031. - That channel is forecast to grow at a 5.1% CAGR. - North America holds the largest global market share and is expected to keep that lead through 2031. - Asia-Pacific is projected to deliver the strongest growth rate. - COVID-19 disrupted supply chains, restricted cross-border trade and hurt on-premise sales. - Online retail helped offset some of that pressure and supported market penetration during the pandemic.

Between the lines: - The report points to a market shaped by injury recovery needs, channel mix and product variation rather than by one single end-use trend. - North America’s lead suggests mature adoption and product development, while Asia-Pacific’s growth outlook signals room for expansion. - Product launches and geographic expansion are the main strategies highlighted for market players. - The report names A. Algeo Ltd., Bird and Cronin, Breg, DJO, DoctorschoiceDME, Henry Schein, Össur, Safte S.p.A., Steeper Inc. and Chengli Medical Equipment Co., Ltd. as key players.

What's next: - Manufacturers are expected to keep prioritizing product innovation and broader geographic reach. - The report says buyers can use the analysis to identify partners, shape licensing strategies, assess competitors and support R&D planning. - Related market reports listed by Allied Market Research include disposable hygiene footwear, trail running shoes, diabetic socks and tactical footwear.